The Journal of Immunology, Vol 143, Issue 12 4141-4145, Copyright © 1989 by American Association of Immunologists

ARTICLES

Adenosine receptors are expressed during differentiation of monocytes to macrophages in vitro. Implications for regulation of phagocytosis

BA Eppell, AM Newell and EJ Brown
Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110.

Ingestion by phagocytes is known to be markedly enhanced by physiologic signals such as cytokines and extracellular matrix proteins which may be found in inflammatory sites. Little investigation has been made of mechanisms that may depress this increased rate of phagocytosis during resolution of inflammation. We show that adenosine can act as an inhibitor of phagocytosis by macrophages derived from in vitro culture of human peripheral blood monocytes. Adenosine (Ado) is equally effective at inhibiting IgG Fc and complement-mediated phagocytosis. However, Ado has no effect on phagocytosis by freshly isolated monocytes. Inhibition by Ado begins after 2 days in culture and reaches a plateau by 5 days; these kinetics of induction of inhibition of phagocytosis parallel an increase in specific Ado binding to the macrophage plasma membrane. Ado binds to cultured monocytes with a Kd of 6 microM. This affinity and the observation that 2-chloroadenosine and 5'-N-ethylcarboxamidadenosine are the most potent inhibitors of phagocytosis suggest that the Ado receptors expressed during monocyte differentiation are of the A2 type. The inhibition of phagocytosis may be mediated by cAMP, a second messenger coupled to A2 receptors in several cell types. Thus, plasma membrane expression of A2 receptors dramatically increases during monocyte differentiation in vitro. These data show that a potentially physiologic mediator can have very different effects on the function of monocytes and macrophages. This suggests a mechanism whereby phagocytic function at inflammatory sites can be down-regulated if and only if signals for the recruitment of new phagocytes have subsided.

This article has been cited by other articles:

				S. Morello, K. Ito, S. Yamamura, K.-Y. Lee, E. Jazrawi, P. DeSouza, P. Barnes, C. Cicala, and I. M. Adcock IL-1beta and TNF-{alpha} Regulation of the Adenosine Receptor (A2A) Expression: Differential Requirement for NF-{kappa}B Binding to the Proximal Promoter J. Immunol., November 15, 2006; 177(10): 7173 - 7183. [Abstract] [Full Text] [PDF]

				W. R. Law Adenosine receptors in the response to sepsis: what do receptor-specific knockouts tell us? Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2006; 291(4): R957 - R958. [Full Text] [PDF]

				Z. H. Nemeth, B. Csoka, J. Wilmanski, D. Xu, Q. Lu, C. Ledent, E. A. Deitch, P. Pacher, Z. Spolarics, and G. Hasko Adenosine A2A Receptor Inactivation Increases Survival in Polymicrobial Sepsis J. Immunol., May 1, 2006; 176(9): 5616 - 5626. [Abstract] [Full Text] [PDF]

				A. Thiele, R. Kronstein, A. Wetzel, A. Gerth, K. Nieber, and S. Hauschildt Regulation of Adenosine Receptor Subtypes during Cultivation of Human Monocytes: Role of Receptors in Preventing Lipopolysaccharide-Triggered Respiratory Burst Infect. Immun., March 1, 2004; 72(3): 1349 - 1357. [Abstract] [Full Text] [PDF]

				H. Zhong, S. G. Shlykov, J. G. Molina, B. M. Sanborn, M. A. Jacobson, S. L. Tilley, and M. R. Blackburn Activation of Murine Lung Mast Cells by the Adenosine A3 Receptor J. Immunol., July 1, 2003; 171(1): 338 - 345. [Abstract] [Full Text] [PDF]

				R. Polosa Adenosine-receptor subtypes: their relevance to adenosine-mediated responses in asthma and chronic obstructive pulmonary disease Eur. Respir. J., August 1, 2002; 20(2): 488 - 496. [Abstract] [Full Text] [PDF]

				J. L. Chunn, H. W. J. Young, S. K. Banerjee, G. N. Colasurdo, and M. R. Blackburn Adenosine-Dependent Airway Inflammation and Hyperresponsiveness in Partially Adenosine Deaminase-Deficient Mice J. Immunol., October 15, 2001; 167(8): 4676 - 4685. [Abstract] [Full Text] [PDF]

				M. R. Blackburn, J. B. Volmer, J. L. Thrasher, H. Zhong, J. R. Crosby, J. J. Lee, and R. E. Kellems Metabolic Consequences of Adenosine Deaminase Deficiency in Mice Are Associated with Defects in Alveogenesis, Pulmonary Inflammation, and Airway Obstruction J. Exp. Med., July 10, 2000; 192(2): 159 - 170. [Abstract] [Full Text] [PDF]

				N. FLAMAND, S. BOUDREAULT, S. PICARD, M. AUSTIN, M. E. SURETTE, H. PLANTE, E. KRUMP, M.-J. VALLEE, C. GILBERT, P. NACCACHE, et al. Adenosine, a Potent Natural Suppressor of Arachidonic Acid Release and Leukotriene Biosynthesis in Human Neutrophils Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): S88 - 94. [Full Text] [PDF]

				M. Koshiba, D. L. Rosin, N. Hayashi, J. Linden, and M. V.  Sitkovsky Patterns of A2A Extracellular Adenosine Receptor Expression in Different Functional Subsets of Human Peripheral T Cells. Flow Cytometry Studies with Anti-A2A Receptor Monoclonal Antibodies Mol. Pharmacol., March 1, 1999; 55(3): 614 - 624. [Abstract] [Full Text]